Article

VIDEO: Andrew J. M. Boulton, MD, Discusses Adherence With Non-Invasive Devices

Andrew J. M. Boulton, MD, describes the impact of non-invasive glucose monitoring devices on adherence and hospital admission rates.

Andrew J. M. Boulton, MD, describes the impact of non-invasive glucose monitoring devices on patient monitoring adherence and hospital admission rates and costs. Theoretically, patients using non-invasive glucose monitoring devices will better adhere to regular monitoring than with invasive devices; however, Dr. Boulton says that there is a need for controlled trials to provide evidence-based data to support this conclusion.

This video was taken on June 8, 2012, at the American Diabetes Association's 72nd Scientific Session in Philadelphia, PA.

Related Videos
Screenshot of an interview with Nadine Barrett, PhD
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester
Screenshot of Susan Wescott, RPh, MBA
Screenshot of an interview with Adam Colborn, JD
Screenshot of an interview with James Chambers, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo